Eli Lilly Wins U.K. Patent Suit on J&J Alzheimer’s Research

Eli Lilly & Co. won a U.K. patent lawsuit against a Johnson & Johnson unit over a potential treatment for Alzheimer’s disease.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.